Annual EBIT
-$14.64 M
+$12.44 M+45.94%
December 31, 2023
Summary
- As of February 26, 2025, RSLS annual earnings before interest & taxes is -$14.64 million, with the most recent change of +$12.44 million (+45.94%) on December 31, 2023.
- During the last 3 years, RSLS annual EBIT has risen by +$5.12 million (+25.92%).
- RSLS annual EBIT is now -670.07% below its all-time high of -$1.90 million, reached on December 31, 2003.
Performance
RSLS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.76 M
+$293.00 K+14.26%
September 30, 2024
Summary
- As of February 26, 2025, RSLS quarterly earnings before interest & taxes is -$1.76 million, with the most recent change of +$293.00 thousand (+14.26%) on September 30, 2024.
- Over the past year, RSLS quarterly EBIT has stayed the same.
- RSLS quarterly EBIT is now at all-time high.
Performance
RSLS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$7.92 M
+$1.34 M+14.49%
September 30, 2024
Summary
- As of February 26, 2025, RSLS TTM earnings before interest & taxes is -$7.92 million, with the most recent change of +$1.34 million (+14.49%) on September 30, 2024.
- Over the past year, RSLS TTM EBIT has stayed the same.
- RSLS TTM EBIT is now -182.47% below its all-time high of -$2.80 million, reached on March 31, 2005.
Performance
RSLS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RSLS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.9% | 0.0% | 0.0% |
| 3 y3 years | +25.9% | 0.0% | 0.0% |
| 5 y5 years | +62.2% | 0.0% | 0.0% |
RSLS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +76.6% | at high | +95.8% | at high | +89.2% |
| 5 y | 5-year | at high | +80.4% | at high | +95.8% | at high | +89.4% |
| alltime | all time | -670.1% | +80.4% | at high | +95.8% | -182.5% | +89.4% |
ReShape Lifesciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.76 M(-14.3%) | -$7.92 M(-14.5%) |
| Jun 2024 | - | -$2.05 M(-7.1%) | -$9.26 M(-17.4%) |
| Mar 2024 | - | -$2.21 M(+16.6%) | -$11.22 M(-23.4%) |
| Dec 2023 | -$14.64 M(-45.9%) | -$1.90 M(-38.9%) | -$14.64 M(-18.6%) |
| Sep 2023 | - | -$3.10 M(-22.6%) | -$17.98 M(-9.0%) |
| Jun 2023 | - | -$4.01 M(-28.8%) | -$19.74 M(-19.7%) |
| Mar 2023 | - | -$5.63 M(+7.6%) | -$24.60 M(-9.2%) |
| Dec 2022 | -$27.08 M(-56.7%) | -$5.23 M(+7.4%) | -$27.08 M(-57.3%) |
| Sep 2022 | - | -$4.87 M(-45.0%) | -$63.49 M(-13.7%) |
| Jun 2022 | - | -$8.86 M(+9.2%) | -$73.60 M(+7.5%) |
| Mar 2022 | - | -$8.11 M(-80.5%) | -$68.44 M(+6.0%) |
| Dec 2021 | -$62.59 M(+216.7%) | -$41.64 M(+177.9%) | -$64.58 M(+107.5%) |
| Sep 2021 | - | -$14.98 M(+304.8%) | -$31.13 M(+50.9%) |
| Jun 2021 | - | -$3.70 M(-12.9%) | -$20.62 M(+4.2%) |
| Mar 2021 | - | -$4.25 M(-48.1%) | -$19.79 M(+0.1%) |
| Dec 2020 | -$19.76 M(-73.5%) | -$8.19 M(+82.9%) | -$19.76 M(-46.4%) |
| Sep 2020 | - | -$4.48 M(+56.3%) | -$36.87 M(-39.6%) |
| Jun 2020 | - | -$2.87 M(-32.2%) | -$61.07 M(-18.0%) |
| Mar 2020 | - | -$4.22 M(-83.3%) | -$74.50 M(-0.2%) |
| Dec 2019 | -$74.65 M(+92.9%) | -$25.30 M(-11.8%) | -$74.65 M(+39.6%) |
| Sep 2019 | - | -$28.68 M(+76.0%) | -$53.48 M(+77.7%) |
| Jun 2019 | - | -$16.29 M(+272.6%) | -$30.09 M(-12.3%) |
| Mar 2019 | - | -$4.37 M(+5.7%) | -$34.32 M(-11.3%) |
| Dec 2018 | -$38.70 M(+18.1%) | -$4.14 M(-21.8%) | -$38.70 M(-10.3%) |
| Sep 2018 | - | -$5.29 M(-74.2%) | -$43.14 M(-9.8%) |
| Jun 2018 | - | -$20.52 M(+134.3%) | -$47.85 M(+40.0%) |
| Mar 2018 | - | -$8.76 M(+2.1%) | -$34.17 M(+4.2%) |
| Dec 2017 | -$32.78 M(+70.2%) | -$8.58 M(-14.2%) | -$32.78 M(+17.4%) |
| Sep 2017 | - | -$9.99 M(+46.1%) | -$27.92 M(+21.1%) |
| Jun 2017 | - | -$6.84 M(-7.1%) | -$23.06 M(+13.2%) |
| Mar 2017 | - | -$7.37 M(+97.8%) | -$20.36 M(+5.8%) |
| Dec 2016 | -$19.26 M(-21.6%) | -$3.72 M(-27.4%) | -$19.26 M(-13.3%) |
| Sep 2016 | - | -$5.13 M(+23.9%) | -$22.20 M(+7.5%) |
| Jun 2016 | - | -$4.14 M(-33.8%) | -$20.66 M(-13.4%) |
| Mar 2016 | - | -$6.26 M(-6.2%) | -$23.86 M(-2.9%) |
| Dec 2015 | -$24.56 M(-4.1%) | -$6.67 M(+86.1%) | -$24.56 M(+2.4%) |
| Sep 2015 | - | -$3.59 M(-51.2%) | -$23.97 M(-7.7%) |
| Jun 2015 | - | -$7.34 M(+5.5%) | -$25.98 M(-0.0%) |
| Mar 2015 | - | -$6.96 M(+14.3%) | -$26.00 M(+1.5%) |
| Dec 2014 | -$25.60 M | -$6.09 M(+8.8%) | -$25.60 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$5.59 M(-24.0%) | -$25.89 M(-1.8%) |
| Jun 2014 | - | -$7.36 M(+12.1%) | -$26.37 M(+5.1%) |
| Mar 2014 | - | -$6.56 M(+3.0%) | -$25.09 M(+1.0%) |
| Dec 2013 | -$24.85 M(+10.2%) | -$6.37 M(+4.9%) | -$24.85 M(-1.5%) |
| Sep 2013 | - | -$6.08 M(+0.1%) | -$25.24 M(+2.0%) |
| Jun 2013 | - | -$6.08 M(-3.9%) | -$24.74 M(+5.8%) |
| Mar 2013 | - | -$6.32 M(-6.5%) | -$23.39 M(+3.7%) |
| Dec 2012 | -$22.56 M(-10.7%) | -$6.76 M(+21.1%) | -$22.56 M(-4.8%) |
| Sep 2012 | - | -$5.58 M(+18.2%) | -$23.70 M(-6.1%) |
| Jun 2012 | - | -$4.72 M(-13.9%) | -$25.25 M(-2.5%) |
| Mar 2012 | - | -$5.49 M(-30.5%) | -$25.91 M(+2.5%) |
| Dec 2011 | -$25.27 M(+57.1%) | -$7.90 M(+10.8%) | -$25.27 M(+20.9%) |
| Sep 2011 | - | -$7.13 M(+32.6%) | -$20.90 M(+17.0%) |
| Jun 2011 | - | -$5.38 M(+10.8%) | -$17.86 M(+7.6%) |
| Mar 2011 | - | -$4.86 M(+37.5%) | -$16.60 M(+3.2%) |
| Dec 2010 | -$16.09 M(-33.6%) | -$3.53 M(-13.7%) | -$16.09 M(-8.4%) |
| Sep 2010 | - | -$4.09 M(-0.5%) | -$17.57 M(-15.3%) |
| Jun 2010 | - | -$4.11 M(-5.4%) | -$20.74 M(-9.3%) |
| Mar 2010 | - | -$4.35 M(-13.3%) | -$22.86 M(-5.6%) |
| Dec 2009 | -$24.21 M(-33.2%) | -$5.02 M(-31.0%) | -$24.21 M(-5.7%) |
| Sep 2009 | - | -$7.27 M(+16.5%) | -$25.66 M(-9.8%) |
| Jun 2009 | - | -$6.23 M(+9.4%) | -$28.46 M(-14.9%) |
| Mar 2009 | - | -$5.70 M(-11.9%) | -$33.45 M(-7.8%) |
| Dec 2008 | -$36.27 M(+29.4%) | -$6.47 M(-35.7%) | -$36.27 M(-5.7%) |
| Sep 2008 | - | -$10.06 M(-10.4%) | -$38.47 M(+10.4%) |
| Jun 2008 | - | -$11.23 M(+31.8%) | -$34.86 M(+15.3%) |
| Mar 2008 | - | -$8.52 M(-1.8%) | -$30.25 M(+6.7%) |
| Dec 2007 | -$28.03 M(+54.7%) | -$8.67 M(+34.4%) | -$28.34 M(+13.8%) |
| Sep 2007 | - | -$6.45 M(-2.4%) | -$24.90 M(+10.2%) |
| Jun 2007 | - | -$6.61 M(0.0%) | -$22.60 M(+12.2%) |
| Mar 2007 | - | -$6.61 M(+26.5%) | -$20.14 M(+13.9%) |
| Dec 2006 | -$18.12 M(+62.5%) | -$5.22 M(+25.7%) | -$17.69 M(+15.9%) |
| Sep 2006 | - | -$4.16 M(0.0%) | -$15.27 M(+9.7%) |
| Jun 2006 | - | -$4.16 M(0.0%) | -$13.92 M(+10.8%) |
| Mar 2006 | - | -$4.16 M(+48.2%) | -$12.57 M(+12.0%) |
| Dec 2005 | -$11.15 M(+223.4%) | -$2.80 M(0.0%) | -$11.22 M(+33.3%) |
| Sep 2005 | - | -$2.80 M(0.0%) | -$8.41 M(+50.0%) |
| Jun 2005 | - | -$2.80 M(0.0%) | -$5.61 M(+100.0%) |
| Mar 2005 | - | -$2.80 M | -$2.80 M |
| Dec 2004 | -$3.45 M(+81.4%) | - | - |
| Dec 2003 | -$1.90 M | - | - |
FAQ
- What is ReShape Lifesciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for ReShape Lifesciences?
- What is ReShape Lifesciences annual EBIT year-on-year change?
- What is ReShape Lifesciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly EBIT year-on-year change?
- What is ReShape Lifesciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ReShape Lifesciences?
- What is ReShape Lifesciences TTM EBIT year-on-year change?
What is ReShape Lifesciences annual earnings before interest & taxes?
The current annual EBIT of RSLS is -$14.64 M
What is the all time high annual EBIT for ReShape Lifesciences?
ReShape Lifesciences all-time high annual earnings before interest & taxes is -$1.90 M
What is ReShape Lifesciences annual EBIT year-on-year change?
Over the past year, RSLS annual earnings before interest & taxes has changed by +$12.44 M (+45.94%)
What is ReShape Lifesciences quarterly earnings before interest & taxes?
The current quarterly EBIT of RSLS is -$1.76 M
What is the all time high quarterly EBIT for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly earnings before interest & taxes is -$1.76 M
What is ReShape Lifesciences quarterly EBIT year-on-year change?
Over the past year, RSLS quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is ReShape Lifesciences TTM earnings before interest & taxes?
The current TTM EBIT of RSLS is -$7.92 M
What is the all time high TTM EBIT for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM earnings before interest & taxes is -$2.80 M
What is ReShape Lifesciences TTM EBIT year-on-year change?
Over the past year, RSLS TTM earnings before interest & taxes has changed by $0.00 (0.00%)